DK3662926T3 - Biologisk aktive insulinderivater - Google Patents

Biologisk aktive insulinderivater Download PDF

Info

Publication number
DK3662926T3
DK3662926T3 DK19208086.9T DK19208086T DK3662926T3 DK 3662926 T3 DK3662926 T3 DK 3662926T3 DK 19208086 T DK19208086 T DK 19208086T DK 3662926 T3 DK3662926 T3 DK 3662926T3
Authority
DK
Denmark
Prior art keywords
biologically active
insulin derivatives
active insulin
derivatives
biologically
Prior art date
Application number
DK19208086.9T
Other languages
English (en)
Inventor
Kleomenis Barlos
Dimitrios Gatos
Kostas Barlos
Michail Ziovas
Original Assignee
Chemical & Biopharmaceutical Laboratories Of Patras S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemical & Biopharmaceutical Laboratories Of Patras S A filed Critical Chemical & Biopharmaceutical Laboratories Of Patras S A
Application granted granted Critical
Publication of DK3662926T3 publication Critical patent/DK3662926T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK19208086.9T 2013-12-05 2014-12-04 Biologisk aktive insulinderivater DK3662926T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1321489.5A GB201321489D0 (en) 2013-12-05 2013-12-05 Biologically active insulin derivatives
EP14833536.7A EP3076990B1 (en) 2013-12-05 2014-12-04 Biologically active insulin derivatives

Publications (1)

Publication Number Publication Date
DK3662926T3 true DK3662926T3 (da) 2023-12-11

Family

ID=50000217

Family Applications (2)

Application Number Title Priority Date Filing Date
DK14833536.7T DK3076990T3 (da) 2013-12-05 2014-12-04 Biologisk aktive insulinderivater
DK19208086.9T DK3662926T3 (da) 2013-12-05 2014-12-04 Biologisk aktive insulinderivater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK14833536.7T DK3076990T3 (da) 2013-12-05 2014-12-04 Biologisk aktive insulinderivater

Country Status (12)

Country Link
US (1) US10195287B2 (da)
EP (2) EP3076990B1 (da)
JP (1) JP6798883B2 (da)
CN (3) CN105793283A (da)
AU (2) AU2014358699A1 (da)
DK (2) DK3076990T3 (da)
ES (2) ES2965765T3 (da)
GB (1) GB201321489D0 (da)
HK (1) HK1223834A1 (da)
IL (1) IL245983B (da)
PL (1) PL3662926T3 (da)
WO (1) WO2015083114A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201321489D0 (en) 2013-12-05 2014-01-22 Chemical & Biopharmaceutical Lab Of Patras S A Biologically active insulin derivatives
EP3509625A1 (en) * 2016-09-06 2019-07-17 Chemical & Biopharmaceutical Laboratories of Patras S.A. Proinsulin derivatives

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3847893A (en) * 1972-03-01 1974-11-12 Bayer Ag Process for the preparation of insulin derivatives cross-linked by a dicarboxylic acid group at the amino a-1 glycine and amino b-29 lysine
DK58285D0 (da) 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
DK10191D0 (da) 1991-01-22 1991-01-22 Novo Nordisk As Hidtil ukendte peptider
WO1995016708A1 (en) 1993-12-17 1995-06-22 Novo Nordisk A/S Proinsulin-like compounds
EP0741188A3 (en) 1995-05-05 1999-07-14 Eli Lilly And Company Single chain insulin with high bioactivity
GB9812675D0 (en) 1998-06-11 1998-08-12 Univ Edinburgh Peptides
EP1193272B1 (en) 2000-10-02 2004-06-30 Yonsei University Single-chain insulin analogs
EP1692168B1 (en) * 2003-12-03 2011-07-20 Novo Nordisk A/S Single-chain insulin
JP2008528549A (ja) * 2005-01-27 2008-07-31 ノボ ノルディスク アクティーゼルスカブ 構造的に充分に定義された分岐ポリマーと接合されたインスリン誘導体
JP2008533100A (ja) 2005-03-18 2008-08-21 ノボ ノルディスク アクティーゼルスカブ Peg化された単鎖インスリン
US20090069216A1 (en) 2006-02-21 2009-03-12 Novo Nordisk A/S Single-Chain Insulin Analogues and Pharmaceutical Formulations Thereof
JP2009530243A (ja) 2006-03-13 2009-08-27 ノボ・ノルデイスク・エー/エス アシル化単鎖インスリン
WO2008043033A2 (en) 2006-10-04 2008-04-10 Case Western Reserve University Fibrillation-resistant insulin and insulin analogues
US9150633B2 (en) * 2007-08-15 2015-10-06 Novo Nordisk A/S Insulin analogues with an acyl and alkylene glycol moiety
US8618049B2 (en) * 2009-09-08 2013-12-31 Stephen B. H. Kent Ester insulin
JP5969469B2 (ja) * 2010-06-16 2016-08-17 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation インスリン受容体に対して高い活性を示す単鎖インスリンアゴニスト
BR112014015156A2 (pt) * 2011-12-20 2020-10-27 Indiana University Research And Technology Corporation análogos de insulina à base de ctp, seus métodos de produção e uso no tratamento de hiperglicemia, bem como sequência de ácido nucleico e célula hospedeira
GB201321489D0 (en) 2013-12-05 2014-01-22 Chemical & Biopharmaceutical Lab Of Patras S A Biologically active insulin derivatives

Also Published As

Publication number Publication date
ES2965765T3 (es) 2024-04-16
IL245983B (en) 2020-03-31
CA2931439A1 (en) 2015-06-11
JP2017501991A (ja) 2017-01-19
GB201321489D0 (en) 2014-01-22
WO2015083114A2 (en) 2015-06-11
ES2773960T3 (es) 2020-07-15
CN118909080A (zh) 2024-11-08
US10195287B2 (en) 2019-02-05
AU2014358699A1 (en) 2016-06-09
US20160375146A1 (en) 2016-12-29
AU2017248496B2 (en) 2019-08-29
PL3662926T3 (pl) 2024-05-13
AU2017248496A1 (en) 2017-11-09
EP3076990A2 (en) 2016-10-12
CN105793283A (zh) 2016-07-20
HK1223834A1 (zh) 2017-08-11
EP3662926B1 (en) 2023-10-25
IL245983A0 (en) 2016-07-31
DK3076990T3 (da) 2020-03-16
EP3076990B1 (en) 2020-01-22
JP6798883B2 (ja) 2020-12-09
WO2015083114A3 (en) 2015-11-26
CN118909079A (zh) 2024-11-08
EP3662926A1 (en) 2020-06-10

Similar Documents

Publication Publication Date Title
DK2968880T3 (da) Lægemiddelafgivelsesindretninger med lægemiddelpermeabel komponent
EP2968894A4 (en) MEDICAL CONNECTOR
DK4056212T3 (da) Autoinjektor
PL3623002T3 (pl) Cewnik
BR112016009485A2 (pt) Inalador de medicamento
EP3750590C0 (en) THRESHOLD RELEASE ADMINISTRATION CAPSULE
EP2968867C0 (en) CATHETER ASSEMBLY
DK2900645T3 (da) Herbicidt aktive 3-phenylisoxazolinderivater
DK3590566T3 (da) Kropsbåret injektor
EP2982401A4 (en) Drug injection syringe
EP2967969C0 (en) IMPLANT
DK2970389T3 (da) Farmaceutiske forbindelser
DK3038674T3 (da) Medikamentafgivelsesindretning
HUE060756T2 (hu) Fungicid hatású készítmények
BR112016011147A2 (pt) autoinjetor
IL240782B (en) Stent
BR112016014772A2 (pt) derivados dihidro-hidantoína com atividade herbicida
PL2945641T3 (pl) Cykloalkinowe pochodne sacharydów
DK2967936T3 (da) Skrå stent
DK3089778T3 (da) Ballonkateter
PT2980085T (pt) Compostos farmaceuticamente activos
DK2983747T3 (da) Lægemiddelindgivelsesindretning
BR112015028948A2 (pt) gerenciamento de entrega de medicamento
EP3000444A4 (en) STENT
DK3662926T3 (da) Biologisk aktive insulinderivater